Renal Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Renal Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2017-07-02Clinical Trial Update: A Pilot, Open-label Study of 18F-Fluciclatide PET/CT Imaging in the Evaluation of Anti-angiogenic Therapy in Solid Tumors [Phase 1, Phase 2]
The trial evaluating 18F-Fluciclatide PET/CT imaging for anti-angiogenic therapy in solid tumors has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-10-19Clinical Trial Update: Efficacy and Safety Study of rhuMAb VEGF to Treat Metastatic Renal Cell Carcinoma [Phase 3]
A Phase 3 trial of bevacizumab (rhuMAb VEGF) for metastatic renal cell carcinoma has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-07-27Clinical Trial Update: Zero Ischemia Laparoscopic Partial Nephrectomy [Phase 2, Phase 3]
Clinical trial update for zero ischemia laparoscopic partial nephrectomy (Phase 2/3) with status withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-07-27Clinical Trial Update: Cryoablation Versus Radiofrequency Ablation for Small Renal Masses [Phase 2]
Phase 2 clinical trial comparing cryoablation and radiofrequency ablation for small renal masses has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-03-24Clinical Trial Update: Bevacizumab With or Without Sunitinib in Sunitinib-Refractory Renal Cell Carcinoma [Phase 2]
A clinical trial evaluating bevacizumab with or without sunitinib in sunitinib-refractory renal cell carcinoma has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2016-03-03Clinical Trial Update: A Pilot Study of SBRT With Adjuvant Pazopanib for Renal Cell Cancer [NA]
This clinical trial (NCT02307474) evaluating SBRT with adjuvant pazopanib for renal cell carcinoma has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-11-23Clinical Trial Update: Functional Imaging in the Assessment of mRCC Response to Sunitinib [NA]
A clinical trial evaluating functional imaging to assess metastatic renal cell carcinoma response to sunitinib has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-11-13Clinical Trial Update: Peripheral Stem Cell Transplantation in Treating Patients With Melanoma or Small Cell Lung, Breast, Testicular, or Kidney Cancer That is Metastatic or That Cannot Be Treated With Surgery [Phase 1]
Phase 1 trial of peripheral stem cell transplantation for metastatic or unresectable cancers including breast cancer, renal cell carcinoma, …
-
CLINICAL_TRIALS withdrawal · 2015-08-26Clinical Trial Update: Fluorescence Imaging on the da Vinci Surgical System for Intraoperative Near Infrared Imaging [NA]
A clinical trial evaluating fluorescence imaging with the da Vinci surgical system for intraoperative near-infrared imaging in renal tumor s…
-
CLINICAL_TRIALS withdrawal · 2015-08-03Clinical Trial Update: Treatment of Advanced Renal Cell Carcinoma With Quinacrine [Phase 2]
A Phase 2 trial of quinacrine for advanced renal cell carcinoma has been withdrawn, per the study update from Cleveland BioLabs.
-
CLINICAL_TRIALS withdrawal · 2015-06-18Clinical Trial Update: Randomized Phase 2 Trial of Pre-chemotherapy Leukine vs. Leukine-Dexamethasone in Combination With Gemzar & 5-FU in Patients With Metastatic Renal Cell Carcinoma [Phase 2]
A randomized Phase 2 trial in metastatic renal cell carcinoma comparing pre-chemotherapy Leukine versus Leukine with dexamethasone, in combi…
-
CLINICAL_TRIALS withdrawal · 2015-01-30Clinical Trial Update: Study to Observe Safety and Efficacy of Nexavar in Treatment of Kidney Cancer
A clinical trial evaluating Nexavar (sorafenib) for renal cell carcinoma has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2014-05-30Clinical Trial Update: Clinical Study With Axitinib In Advanced Kidney Cancer, Who Have Failed First Line Treatment
Pfizer-sponsored trial evaluating axitinib in patients with advanced renal cell carcinoma after failure of first-line therapy has been withd…
-
CLINICAL_TRIALS withdrawal · 2013-08-13Clinical Trial Update: Study of Cryotherapy for Renal Tumors [NA]
A clinical trial studying cryotherapy for renal tumors has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-07-11Clinical Trial Update: Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Recurrent Kidney Cancer [Phase 2]
A Phase 2 trial evaluating peripheral stem cell transplantation for metastatic or recurrent renal cell carcinoma has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-07-10Clinical Trial Update: BAY 56-3722 in Treating Patients With Recurrent, Unresectable, or Metastatic Kidney Cancer [Phase 2]
A Phase 2 trial evaluating BAY 56-3722 for recurrent, unresectable, or metastatic renal cell carcinoma has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-06-19Clinical Trial Update: Tivozanib + Gemcitabine in Metastatic RCC [Phase 2]
A Phase 2 trial of tivozanib plus gemcitabine in metastatic renal cell carcinoma has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-05-23Clinical Trial Update: Interferon Alpha-2b (Intron A) for Metastatic or Unresectable Clear Cell Renal Carcinoma [Phase 2]
Phase 2 trial of interferon alfa-2b (Intron A) for metastatic or unresectable clear cell renal cell carcinoma has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-05-01Clinical Trial Update: A Post Marketing Surveillance As Required By Philippine Food And Drug Administration
Pfizer-sponsored post-marketing surveillance study for renal cell carcinoma has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-04-08Clinical Trial Update: Everolimus/Sorafenib or Sunitinib in Patients With Metastatic Renal Cell Carcinoma (RCC) [Phase 2]
A Phase 2 trial investigating Everolimus in combination with Sorafenib or Sunitinib for metastatic renal cell carcinoma has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-02-27Clinical Trial Update: RF Ablation of Treatment of Metastatic Lesions in Patients Undergoing Antiangiogenic Therapy for Stage IV Renal Cell Carcinoma [NA]
This clinical trial investigating radiofrequency ablation of metastatic lesions in patients receiving antiangiogenic therapy for stage IV re…
-
CLINICAL_TRIALS withdrawal · 2013-02-20Clinical Trial Update: S0351, CNTO 328 in Treating Patients With Unresectable or Metastatic Kidney Cancer [Phase 2]
SWOG trial S0351 evaluating CNTO 328 for unresectable or metastatic kidney cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2012-07-31Clinical Trial Update: Study of Sunitinib in Subjects With High Risk Renal Cell Carcinoma [Phase 2]
A Phase 2 study of sunitinib in patients with high-risk renal cell carcinoma has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2012-02-22Clinical Trial Update: Chemotherapy in Treating Patients With Unresectable Primary or Metastatic Kidney Cancer [Phase 2]
A Phase 2 trial evaluating chemotherapy for unresectable primary or metastatic kidney cancer has been withdrawn from the study.
-
CLINICAL_TRIALS withdrawal · 2011-12-20Clinical Trial Update: A Study Of Crizotinib Plus VEGF Inhibitor Combinations In Patients With Advanced Solid Tumors. [Phase 1]
A Phase 1 clinical trial evaluating crizotinib in combination with a VEGF inhibitor for advanced solid tumors has been withdrawn.